ici 204,219 has been researched along with Reperfusion Injury in 2 studies
zafirlukast: a leukotriene D4 receptor antagonist
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahmoud, HM | 1 |
| Elsayed Abouzed, DE | 1 |
| Abo-Youssef, AM | 1 |
| Hemeida, RAM | 1 |
| Hagar, HH | 1 |
| Abd El Tawab, R | 1 |
2 other studies available for ici 204,219 and Reperfusion Injury
| Article | Year |
|---|---|
Zafirlukast protects against hepatic ischemia-reperfusion injury in rats via modulating Bcl-2/Bax and NF-κB/SMAD-4 pathways.
Topics: Animals; bcl-2-Associated X Protein; Biomarkers; Cytokines; Liver; Male; NF-kappa B; Oxidative Stres | 2023 |
Cysteinyl leukotriene receptor antagonism alleviates renal injury induced by ischemia-reperfusion in rats.
Topics: Animals; Disease Models, Animal; Indoles; Intercellular Adhesion Molecule-1; Kidney Diseases; Leukot | 2012 |